Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.61 +0.01 (+0.62%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) Property, Plant & Equipment (Net) Growth (3y) (2025 - 2026)

Cadrenal Therapeutics (CVKD) Property, Plant & Equipment (Net) Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 14.05%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 11.65%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 411.50%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -3.34%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 16.78%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.66%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 109.44%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 19.96%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cadrenal Therapeutics 4.59 Mn 2.19 Mn - -8.40%

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.40%
Mar 31, 2026 77.71%
Dec 31, 2025 72.22%